Page 58 - Genetic Engineering News Today

Havana, Apr 27 (Prensa Latina) Mambisa, Cuba's only anti-Covid-19 vaccine candidate administered nasally, managed to get more than 70 percent of the volunteers participating in the clinical study to increase their antibody titers fourfold, they reported today.

NEW YORK, April 26, 2022 /PRNewswire/ -- The Insight Partners published latest research study on "Synthetic Biology Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Products

Havana, Apr 26 (Prensa Latina) The Prime Minister of Dominica, Roosevelt Skerrit, spoke highly today of Cuban advances in biotechnology, and praised the aid provided by the Antillean nation to other countries in the field of health.

/PRNewswire/ -- The Insight Partners published latest research study on "Synthetic Biology Market Forecast to 2028 - COVID-19 Impact and Global Analysis By...

/PRNewswire/ -- The Insight Partners published latest research study on "Synthetic Biology Market Forecast to 2028 - COVID-19 Impact and Global Analysis By...

Forcefield Therapeutics launches today following £5.5m commitment from Syncona New biotechnology company launched to develop pioneering, best-in-class therapeutics to protect

The startup Forcefield Therapeutics has been unveiled in the UK with €6M (£5.5M) backing from the investment firm Syncona. The mission is to develop the first drugs to safeguard heart muscle from damage during heart attacks.

A new dual delivery system designed to sequentially release BMP2 and IGF1 in microparticles in an injectable hydrogel successfully healed an 8-mm cranial defect in rats.

Novel Food Safety Assessments In Indonesia, Thailand, And Vietnam. Legal News and Analysis - Asia Pacific, Indonesia, Thailand, Vietnam - Regulatory & Compliance -

A new study examined possible genetic engineering approaches that could be utilized to tailor the metabolic processes of yeasts, bacteria, and thraustochytrids to optimize the synthesis of squalene.